Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
Clinical trial NCT06554509 · RECRUITING
Trial details
- NCT number
- NCT06554509
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-19
- Primary completion
- 2028-10-01
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.